The good news is, I don't believe you to be one of the scammers (like monroe and a couple others)...
however, I'm not quite convinced that 7 years is enough education for you...for instance...tell me the post below was before you came to your senses and and at the very least, sold off your cost basis??
Blueheel1
Re: None
Tuesday, June 30, 2020 8:56:01 PM
Post#
89335
of 233356
So, sitting out on my back porch having a glass of wine with my wife, and I told her that we “lost more money today than I have made in my five best years of working“. And then I just started laughing. I think maybe she thinks I have lost it :)
This has been a crazy journey for sure. Never thought I would be in a position to lose as much money as I did today. At the same time, I firmly believe that we will surpass the $10 mark before we see August - and up from there. When you have something great, you attract attention and become a target – – which is what we became today. But what we own as shareholders is beyond what any two bit short seller can touch.
No, it didn’t feel great losing that much money today – – but I continue to try to enjoy this journey. I think this will be a once-in-a-lifetime run for me – – never before have I seen anything with this much potential, and I don’t think I will ever see it again. These are twists and turns in a world class drama that will have an ending that beats anything we’ve seen - saving and improving many lives, and making a lot of millionaires and multi millionaires along the way!
Now, time to pour another glass....
You watched a stock get pumped and dumped badly, even to the point the CEO was prosecuted for fraud, and yet you still believe penny stocks are a viable way to make money?
I've had people on IHUB who were able to admit to me later they should have listened, but most are too stubborn to admit it. I wonder which you will be?
Just my opinion, of course.
Recent RNXT News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/16/2026 09:10:26 PM
- Clinical Data Supporting Targeted Chemotherapeutic Delivery via RenovoRx’s TAMP™ Therapy Platform Presented at 2026 SIR Annual Scientific Meeting • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 04/09/2026 02:19:11 PM
- RenovoRx Secures First Notice of Allowance for Japanese Patent Covering its RenovoCath® Device for Targeted, Local Drug-Delivery via the Vasa Vasorum • GlobeNewswire Inc. • 04/08/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 12:00:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 12:00:03 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2026 12:00:02 AM
- RenovoRx Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026 • GlobeNewswire Inc. • 04/01/2026 06:20:16 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/31/2026 08:19:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:38:46 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:34:03 PM
- RenovoRx Reports Full Year 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/30/2026 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 11:00:10 AM
- RenovoRx Announces Key Phase III Milestone: TIGeR-PaC Trial Surpasses 100 Randomized Patients as Study Nears Completion of Enrollment • GlobeNewswire Inc. • 03/26/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 01:16:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 01:16:41 AM
- RenovoRx Announces Closing of Oversubscribed $10 Million at Market Private Placement • GlobeNewswire Inc. • 03/23/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 11:00:38 AM
- RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET • GlobeNewswire Inc. • 03/20/2026 12:30:00 PM
- RenovoRx Announces $10 Million at Market Private Placement • GlobeNewswire Inc. • 03/18/2026 12:35:18 PM
- RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum • GlobeNewswire Inc. • 02/27/2026 01:30:00 PM
- RenovoRx Announces Acceptance of Clinical Data Abstract at 2026 Society of Interventional Radiology Annual Scientific Meeting • GlobeNewswire Inc. • 02/26/2026 01:30:00 PM
- RenovoRx Establishes RenovoCath® Medical Advisory Board • GlobeNewswire Inc. • 02/10/2026 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/06/2026 12:00:43 PM
- RenovoRx Appoints Experienced Public Company Executive Mark Voll as Chief Financial Officer • GlobeNewswire Inc. • 02/05/2026 01:30:00 PM
